BR0314115A - Utilização de mutantes erg4 de saccharomyces cerevisiae para expressão de transportadores de glicose de mamìferos - Google Patents

Utilização de mutantes erg4 de saccharomyces cerevisiae para expressão de transportadores de glicose de mamìferos

Info

Publication number
BR0314115A
BR0314115A BR0314115-2A BR0314115A BR0314115A BR 0314115 A BR0314115 A BR 0314115A BR 0314115 A BR0314115 A BR 0314115A BR 0314115 A BR0314115 A BR 0314115A
Authority
BR
Brazil
Prior art keywords
erg4
mutants
expression
saccharomyces cerevisiae
glucose transporters
Prior art date
Application number
BR0314115-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Guenter Mueller
Silke Dlugai
Doerthe Voss
Eckhard Boles
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of BR0314115A publication Critical patent/BR0314115A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C12N1/18—Baker's yeast; Brewer's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR0314115-2A 2002-09-14 2003-09-04 Utilização de mutantes erg4 de saccharomyces cerevisiae para expressão de transportadores de glicose de mamìferos BR0314115A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10242763A DE10242763A1 (de) 2002-09-14 2002-09-14 Verwendung von Saccharomyces cerevisiae erg4-Mutanten zur Expression von Glukosetransportern aus Säugetieren
PCT/EP2003/009812 WO2004026907A2 (de) 2002-09-14 2003-09-04 Verwendung von saccharomyces cerevisiae erg4-mutanten zur expression von glukosetransportern aus säugetieren

Publications (1)

Publication Number Publication Date
BR0314115A true BR0314115A (pt) 2005-07-12

Family

ID=31724774

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314115-2A BR0314115A (pt) 2002-09-14 2003-09-04 Utilização de mutantes erg4 de saccharomyces cerevisiae para expressão de transportadores de glicose de mamìferos

Country Status (15)

Country Link
EP (1) EP1539958A2 (ko)
JP (1) JP4520854B2 (ko)
KR (1) KR101233998B1 (ko)
CN (1) CN1694960B (ko)
AU (1) AU2003264257B2 (ko)
BR (1) BR0314115A (ko)
CA (1) CA2498636C (ko)
DE (1) DE10242763A1 (ko)
HK (1) HK1084401A1 (ko)
IL (2) IL167321A (ko)
MX (1) MXPA05002816A (ko)
NO (1) NO20051795L (ko)
RU (1) RU2345136C2 (ko)
WO (1) WO2004026907A2 (ko)
ZA (1) ZA200501871B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102899328A (zh) * 2012-09-28 2013-01-30 南京农业大学 山羊葡萄糖转运载体4基因及其重组表达载体和应用
CN110408616B (zh) * 2019-07-09 2021-06-15 中南民族大学 GLUT4基因敲除的sgRNA、A549细胞系及其构建方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5942398A (en) * 1998-02-26 1999-08-24 Millennium Pharmaceuticals, Inc. Nucleic acid molecules encoding glutx and uses thereof
AU5477500A (en) * 1999-06-09 2000-12-28 General Hospital Corporation, The Method of measuring plasma membrane targeting of glut4
DE10106718A1 (de) * 2001-02-14 2002-09-05 Aventis Pharma Gmbh Hefestamm von Saccharomyces cerevisiae mit funktioneller Expression eines Glut-Transporters

Also Published As

Publication number Publication date
JP4520854B2 (ja) 2010-08-11
CA2498636C (en) 2012-04-17
CN1694960A (zh) 2005-11-09
KR20050056206A (ko) 2005-06-14
KR101233998B1 (ko) 2013-02-18
WO2004026907A2 (de) 2004-04-01
JP2006517088A (ja) 2006-07-20
IL167321A (en) 2013-11-28
HK1084401A1 (en) 2006-07-28
IL197621A (en) 2014-01-30
CA2498636A1 (en) 2004-04-01
MXPA05002816A (es) 2005-05-27
AU2003264257A1 (en) 2004-04-08
CN1694960B (zh) 2010-05-12
WO2004026907A3 (de) 2004-11-11
DE10242763A1 (de) 2004-03-18
AU2003264257B2 (en) 2010-05-20
RU2005110955A (ru) 2006-01-20
IL197621A0 (en) 2011-08-01
RU2345136C2 (ru) 2009-01-27
NO20051795L (no) 2005-06-08
EP1539958A2 (de) 2005-06-15
ZA200501871B (en) 2005-10-26

Similar Documents

Publication Publication Date Title
NO2017027I1 (no) efmoroctocog alfa eller et biotilsvarende legemiddel ihht Artikkel 10(4) av Directive 2001/83/EC, som beskyttet av basispatentet.
ATE405650T1 (de) Produktion von ganzen antikörpern in prokaryontischen zellen
WO2006085984A3 (en) Immune cell biosensors and methods of using same
WO2006073748A3 (en) Antibodies against antigen presenting cells and uses thereof
WO2006076025A3 (en) Immune cell biosensors and methods of using same
EP1375651A3 (en) Oral compositions for white blood cell activation and proliferation
WO2004091543A3 (en) Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
WO2005121332A3 (en) Truncated st6galnaci polypeptides and nucleic acids
WO2005003168A3 (en) Methods for the production and cytotoxicity evaluation of kir2dl nk-receptor antibodies
WO2006116181A3 (en) Regulatory t cell mediator proteins and uses thereof
WO2006081008A3 (en) Nucleic acids for apoptosis of cancer cells
BR0317994A (pt) Cepas de levedura recombinante que produzem a fermentação de xilose
WO2004060381A8 (en) Rabbit skin comprising biological active substance and its use
BR0314115A (pt) Utilização de mutantes erg4 de saccharomyces cerevisiae para expressão de transportadores de glicose de mamìferos
ATE340252T1 (de) Cect 11774 und cect 11775 saccharomyces cerevisiae-stämme und ihre verwendung zur fermentativen herstellung alkoholischer getränke und anderer nahrungsmittel
WO2003020904A3 (en) Methods of generating human cd4+ th1 cells
TW200603824A (en) Prostaglandin reductase
AR046187A1 (es) Uso de poli - alfa- 1,4- glucanos lineales como almidones resistentes
HRP20040795A2 (en) Production process of recombinant placental growth factor
WO2013173874A3 (en) Composition and method for management of diabetes or pre-diabetes
WO2003075849A3 (en) Composition and method for enhancing immune response
WO2006091892A3 (en) Methods of producing recombinant proteins
Takashi Northern Studies in Japan
van den Berg et al. ChaMPlane's Bulge Latitude Survey: infrared follow-up
CY1112424T1 (el) Πυρηνικο οξυ και αντιστοιχη πρωτεϊνη με τιτλο 238ρ1β2 χρησιμα στην αγωγη και ανιχνευση του καρκινου

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2322 DE 07-07-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.